Meng Fu

Dr. Meng Fu


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
PQPei Qiao
Pei Qiao
CZChen Zhang
Chen Zhang
JYJinlei Yu
Jinlei Yu
SSShuai Shao
Shuai Shao
JZJieyu Zhang
Jieyu Zhang
GWGang Wang
Gang Wang

1 June 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
ZZZhenlai Zhu
Zhenlai Zhu
JCJiaoling Chen
Jiaoling Chen
YLYiting Lin
Yiting Lin
CZChen Zhang
Chen Zhang
WLWei Li
Wei Li
GWGang Wang
Gang Wang

20 November 2020 in Chinese Medical Journal
Verified
Journal Article
Open access
CXChun-Ying Xiao
Chun-Ying Xiao
ZZZhenlai Zhu
Zhenlai Zhu
CZChen Zhang
Chen Zhang
MFMeng Fu
Meng Fu
HQHongjiang Qiao
Hongjiang Qiao
EDErle Dang
Erle Dang
Background Psoriasis is a common chronic inflammatory skin disease with 2% to 3% prevalence worldwide and a heavy social-psychological burden for patients and their families. As the exact pathogenesis of psoriasis is still unknown, the current treatment is far from satisfactory. Thus, there is an urgent need to find a more effective therapy for this disease. Keratin 17 (K17), a type I intermediate filament, is overexpressed in the psoriatic epidermis and plays a critical pathogenic role by stimulating T cells in psoriasis. Therefore, we hypothesized that inhibiting K17 may be a potential therapeutic approach for psoriasis. This study aimed to investigate the therapeutic effect of K17-specific small interfering RNA (siRNA) on mice with imiquimod (IMQ)-induced psoriasis-like dermatitis. Methods Eight-week-old female BALB/c mice were administered a 5% IMQ cream on both ears to produce psoriatic dermatitis. On day 3, K17 siRNA was mixed with an emulsion matrix and applied topically to the left ears of the mice after IMQ application every day for 7 days. The right ears of the mice were treated in parallel with negative control (NC) siRNA. Inflammation was evaluated by gross ear thickness, histopathology, the infiltration of inflammatory cells (CD3+ T cells and neutrophils) using immunofluorescence, and the expression of cytokine production using real-time quantitative polymerase chain reaction. The obtained data were statistically evaluated by unpaired t-tests and a one-way analysis of variance. Results The severity of IMQ-induced dermatitis on K17 siRNA-treated mice ears was significantly lower than that on NC siRNA-treated mice ears, as evidenced by the alleviated ear inflammation phenotype, including decreased ear thickness, infiltration of inflammatory cells (CD3+ T cells and neutrophils), and inflammatory cytokine/chemokine expression levels (interleukin 17 [IL-17], IL-22, IL-23, C-X-C motif chemokine ligand 1, and C-C motif chemokine ligand 20) (P < 0.05 vs. the Blank or NC siRNA groups). Compared to the NC siRNA treatment, the K17 siRNA treatment resulted in increased K1 and K10 expression, which are characteristic of keratinocyte differentiation (vs. NC siRNA, K17 siRNA1 group: K1, t = 4.782, P = 0.0050; K10, t = 3.365, P = 0.0120; K17 siRNA2 group: K1, t = 4.104, P = 0.0093; K10, t = 4.168, P = 0.0042; siRNA Mix group: K1, t = 3.065, P = 0.0221; K10, t = 10.83, P < 0.0001), and decreased K16 expression, which is characteristic of keratinocyte proliferation (vs. NC siRNA, K17 siRNA1 group: t = 4.156, P = 0.0043; K17 siRNA2 group: t = 2.834, P = 0.0253; siRNA Mix group: t = 2.734, P = 0.0250). Conclusions Inhibition of K17 expression by its specific siRNA significantly alleviated inflammation in mice with IMQ-induced psoriasis-like dermatitis. Thus, gene therapy targeting K17 may be a potential treatment approach for psoriasis.

1 August 2015 in Journal of Dermatological Science
Verified
Journal Article
Closed access
JCJiao Cao
Jiao Cao
CZChen Zhang
Chen Zhang
TCTing Chen
Ting Chen
RTRong Tian
Rong Tian
SSShuhong Sun
Shuhong Sun
WLWei Li
Wei Li

7 May 2024 in Genome Biology
Verified
Journal Article
Open access
PDF file
XGXiaoli Gong
Xiaoli Gong
Wei HeWei He
Wei He
WJWan Jin
Wan Jin
HMHongwei Ma
Hongwei Ma
GWGang Wang
Gang Wang
YWYuan Wei
Yuan Wei
Background: Preeclampsia, one of the most lethal pregnancy-related diseases, is associated with the disruption of uterine spiral artery remodeling during placentation. However, the early molecular events leading to preeclampsia remain unknown.Results: By analyzing placentas from preeclampsia, non-preeclampsia, and twin pregnancies with selective intrauterine growth restriction, we show that the pathogenesis of preeclampsia is attributed to immature trophoblast and maldeveloped endothelial cells. Delayed epigenetic reprogramming during early extraembryonic tissue development leads to generation of excessive immature trophoblast cells. We find reduction of de novo DNA methylation in these trophoblast cells results in selective overexpression of maternally imprinted genes, including the endoretrovirus-derived gene PEG10 (paternally expressed gene 10). PEG10 forms virus-like particles, which are transferred from the trophoblast to the closely proximate endothelial cells. In normal pregnancy, only a low amount of PEG10 is transferred to maternal cells; however, in preeclampsia, excessive PEG10 disrupts maternal vascular development by inhibiting TGF-beta signaling.Conclusions: Our study reveals the intricate epigenetic mechanisms that regulate trans-generational genetic conflict and ultimately ensure proper maternal–fetal interface formation.

14 August 2019 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
YGYanyang Guo
Yanyang Guo
ZZZhenlai Zhu
Zhenlai Zhu
JGJixin Gao
Jixin Gao
CZChen Zhang
Chen Zhang
XZXiujun Zhang
Xiujun Zhang
MFMeng Fu
Meng Fu